Year |
Citation |
Score |
2023 |
Tsujino T, Takai T, Hinohara K, Gui F, Tsutsumi T, Bai X, Miao C, Feng C, Gui B, Sztupinszki Z, Simoneau A, Xie N, Fazli L, Dong X, Azuma H, et al. CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature Communications. 14: 252. PMID 36650183 DOI: 10.1038/s41467-023-35880-y |
0.336 |
|
2022 |
Zhang CS, Li M, Wang Y, Li X, Zong Y, Long S, Zhang M, Feng JW, Wei X, Liu YH, Zhang B, Wu J, Zhang C, Lian W, Ma T, ... ... Gui F, et al. The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. Nature Metabolism. PMID 36217034 DOI: 10.1038/s42255-022-00640-7 |
0.463 |
|
2022 |
Miao C, Tsujino T, Takai T, Gui F, Tsutsumi T, Sztupinszki Z, Wang Z, Azuma H, Szallasi Z, Mouw KW, Zou L, Kibel AS, Jia L. loss overrides PARP inhibitor sensitivity driven by loss in prostate cancer. Science Advances. 8: eabl9794. PMID 35179959 DOI: 10.1126/sciadv.abl9794 |
0.33 |
|
2021 |
Lu Y, Fan Z, Zhu SJ, Huang X, Zhuang Z, Li Y, Deng Z, Gao L, Hong X, Zhang T, Li L, Sun X, Huang W, Zhang J, Liu Y, ... ... Gui F, et al. A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC. Embo Molecular Medicine. e14296. PMID 34845836 DOI: 10.15252/emmm.202114296 |
0.678 |
|
2020 |
Li W, Ni H, Wu S, Han S, Chen C, Li L, Li Y, Gui F, Han J, Deng X. Targeting RIPK3 oligomerization blocks necroptosis without inducing apoptosis. Febs Letters. PMID 32412649 DOI: 10.1002/1873-3468.13812 |
0.673 |
|
2019 |
Gui F, Jiang J, He Z, Li L, Li Y, Deng Z, Lu Y, Wu X, Chen G, Su J, Song S, Zhang YM, Yun CH, Huang X, Weisberg E, et al. A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant Btk mutation in B-cell malignancies. British Journal of Pharmacology. PMID 31364164 DOI: 10.1111/Bph.14809 |
0.704 |
|
2016 |
Jiang J, Gui F, He Z, Li L, Li Y, Li S, Wu X, Deng Z, Sun X, Huang X, Huang W, Han S, Zhang T, Wang Z, Jiao B, et al. Targeting BRK-positive breast cancers with small molecule kinase inhibitors. Cancer Research. PMID 27758886 DOI: 10.1158/0008-5472.Can-16-1038 |
0.521 |
|
2015 |
Wang Y, Qi S, Zhan Y, Zhang N, Wu AA, Gui F, Guo K, Yang Y, Cao S, Hu Z, Zheng Z, Song S, Xu Q, Shen Y, Deng X. Aspertetranones A-D, Putative Meroterpenoids from the Marine Algal-Associated Fungus Aspergillus sp. ZL0-1b14. Journal of Natural Products. PMID 26378981 DOI: 10.1021/Acs.Jnatprod.5B00487 |
0.416 |
|
Show low-probability matches. |